Litigation (Other Litigation) (Narrative) (Details) $ in Millions	Oct. 13, 2016	Sep. 30, 2020 USD ($)
Loss Contingencies [Line Items]
Number of cases		1,000
Other Litigation
Loss Contingencies [Line Items]
Loss Contingency Accrual		$ 8.0
EpiPen Israeli Securities Litigation [Member]
Loss Contingencies [Line Items]
Number of defendants	4
Amended Anticompetitive Conduct with Generic Drugs [Member]
Loss Contingencies [Line Items]
Number of states		43
Anticompetitive conduct with respect to additional generic drugs [Member]
Loss Contingencies [Line Items]
Number of states		46